Abstract:The central role of inflammatory processes in the development of beta-amyloid (Aβ) pathology has been widely shown in rodent models, but has yet to be elucidated in humans, particularly prior to the onset of clinical symptoms. We examined associations between peripheral inflammatory mediators, cognition, and two neuroimaging Alzheimer’s disease (AD) biomarkers, Aβ plaques and hippocampal atrophy, in non-demented older adults. Cross-sectional and longitudinal data were used to assess associations between peripheral inflammatory biomarkers (soluble CD14, TNF-α receptor concentrations, and IL-6) and memory performance on the California Verbal Learning Test (CVLT) and Rey-Osterrieth Complex Figure Test in 173 non-demented older adults. Of these 173 participants, 134 were cognitively normal (CN) and 34 had MCI. Ninety of these participants underwent repeated assessments at 24 months. Structural MRI and Pittsburgh compound B-PET imaging were used to quantify hippocampal volume and Aβ plaque deposition. After adjusting for demographics, linear regression analysis revealed that higher levels of TNF-α and IL-6 predicted poorer global and verbal memory performance in the full sample, and the CN subsample. Elevated concentrations of pro-inflammatory markers were also associated with higher global Aβ deposition, specifically among those that also exhibited greater hippocampal atrophy. Secondary analysis using template-derived regions of interest showed that these moderation effects were specific to PiB uptake in the anterior cingulate gyrus, frontal cortex, and precuneus. These associations remained after adjusting for hypertension, diabetes, heart disease and white matter lesions (all p<0.05). Furthermore, higher levels of circulating IL-6 predicted subsequent conversion to MCI and increased longitudinal accumulation of Aβ pathology in regions susceptible to early amyloid deposition. Hippocampal volume moderated the association between inflammatory markers and Aβ deposition, suggesting potential disease-state-dependent differences in peripheral inflammatory profiles during the preclinical phase of AD. These findings highlight potential protein signatures that may vary depending on the prodromal phase of disease progression, and could help identify those in specific preclinical stages. from CN to MCI. Moreover, chronic, low-level systemic inflammation may accelerate the deposition of Aβ pathology and, consequently, place individuals at a higher risk of developing clinically significant cognitive impairment.

Inflammatory Markers in Younger Vs Elderly Normal Volunteers and in Patients with Alzheimer’s Disease

[Serum Markers in Relation to Cognitive Functioning in an Aging Population: Results of the Maastricht Aging Study (MAAS)].

Inflammation Markers in Relation to Cognition in a Healthy Aging Population

Alterations in immune functions during normal aging and Alzheimer's disease.

IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis

No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer’s disease progression: a longitudinal study

Serotonin-Immune Interactions in Elderly Volunteers and in Patients with Alzheimer'S Disease (dat): Lower Plasma Tryptophan Availability to the Brain in the Elderly and Increased Serum Interleukin-6 in Dat

Alterations in Immune Functions During Normal Aging and Alzheimer's Disease

Inflammatory Markers in Alzheimer’s Disease and Mild Cognitive Impairment: a Meta-Analysis and Systematic Review of 170 Studies

Study on the chronic low-grade inflammation and its related factors in the elderly

Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome

Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 Levels in Alzheimer's: The Relation Between Neuroinflammatory Pathway and Severity of Dementia

Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength

Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study

Peripheral Inflammatory Biomarkers and Cognitive Decline in Older Adults With and Without Alzheimer's Disease: A Systematic Review.

Inflammation and Preclinical AD: Associations between Peripheral Inflammatory Biomarkers, Cognition, and Amyloid-B deposition in Non-demented Older Adults

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Age- and Sex-Different Associations between Cognitive Performance and Inflammatory Biomarkers in Community Dwelling Older Adults: towards Precision Preventive Strategies

Age-Dependent Signature of Serum Inflammatory Cytokines in Healthy Children and Young Adults

Protein signatures from blood plasma and urine suggest changes in vascular function and IL-12 signaling in elderly with a history of chronic diseases compared with an age-matched healthy cohort

Chronic Low-grade Inflammation in the Elderly